CTRI/2023/03/050418尚未招募2 期
A Randomized, Parallel Group, Open Label, Active Controlled Clinical Study to evaluate the Efficacy and Safety of Safoof-i-Ushba and Roghan-i-Banafsha in the Management of Taqashshur al-Jild (Psoriasis)
ational Research Institute of Unani Medicine for Skin Disorders0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patient clinically stable.
- •2. Patient with clinically diagnosed Taqashshur al-jild (psoriasis) of
- •plaque type.
- •3. Psoriasis area severity index (PASI) >=10%
排除标准
- •1. Participants aged <18and >60years
- •2. Known cases of significant Pulmonary/Cardiovascular/ Hepato-renal Dysfunction, Malignancy, HIV infection, AIDS, etc.
- •3. Erythrodermic psoriasis.
- •4. Pregnancy and Lactation.
- •5. Patient not willing to attend treatment regularly.
研究者
相似试验
尚未招募
2 期
Study to evaluate the Efficacy and Safety of a topical Unani Formulation in the Management of EczemaCTRI/2023/03/050218ational Research Institute of Unani Medicine For Skin Disorders
尚未招募
2 期
Clinical study of Unani Formulation in Tinea CorporisCTRI/2024/06/068679ational Research Institute Of Unani Medicine For Skin Disorders
尚未招募
2 期
Evaluating efficacy and safety of Unani Formulation in Tinea Corporis and Tinea CrurisCTRI/2023/11/059444ational Research Institute Of Unani Medicine For Skin Disorders
尚未招募
2 期
Evaluating efficacy of unani formulation in Acne.CTRI/2023/10/058541ational Research Institute of Unani Medicine for Skin Disorders
尚未招募
2 期
A Clinical valuation of efficacy and safety of Unani Formulation in Warm Tajawif al-Anf Muzmin (Chronic Sinusiti).CTRI/2023/03/050256ational Research Institute of Unani Medicine for Skin Disorders, Hyederabad